Cytosorbents
CTSO
#9825
Rank
A$69.08 M
Marketcap
A$1.10
Share price
-1.20%
Change (1 day)
-20.00%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$18.18 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.1 Million. In 2024 the company made an earning of -A$33.59 Million, an increase over its 2023 earnings that were of -A$44.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$18.18 Million-45.88%
2024 -A$33.59 Million-23.97%
2023 -A$44.18 Million-13.52%
2022 -A$51.09 Million34.04%
2021 -A$38.12 Million182.17%
2020 -A$13.51 Million-55.97%
2019 -A$30.68 Million14.17%
2018 -A$26.87 Million95.14%
2017 -A$13.77 Million-22.32%
2016 -A$17.73 Million39.1%
2015 -A$12.75 Million-12.89%
2014 -A$14.63 Million89%
2013 -A$7.74 Million26.65%
2012 -A$6.12 Million-26.02%
2011 -A$8.26 Million-288.45%
2010 A$4.38 M-4.17%
2009 A$4.57 M-287.19%
2008 -A$2.45 Million-47.12%
2007 -A$4.63 Million41.78%
2006 -A$3.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
A$83.63 M-585.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.19 B-7,057.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$4.92 B-28,683.67%๐Ÿ‡บ๐Ÿ‡ธ USA